{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:51:09Z","timestamp":1792144269151,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.sleep.2010.11.002","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T04:11:43Z","timestamp":1295151103000},"page":"440-444","source":"Crossref","is-referenced-by-count":181,"title":["A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome"],"prefix":"10.1016","volume":"12","author":[{"given":"Nathan","family":"Silver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Senerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.sleep.2010.11.002_b0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleep.2010.11.002_b0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(08)70112-1","article-title":"Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Trenkwalder","year":"2008","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.sleep.2010.11.002_b0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.sleep.2007.12.004","article-title":"Open-label study of the long-term efficacy and safety of pramipexole in patients with restless legs syndrome (extension of the PRELUDE study)","volume":"9","author":"Partinen","year":"2008","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2010.11.002_b0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.21261","article-title":"Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study)","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.sleep.2010.11.002_b0025","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/mds.21050","article-title":"Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial","volume":"21","author":"Montplaisir","year":"2006","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.sleep.2010.11.002_b0030","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1468-1331.2006.01459.x","article-title":"Long-term treatment with pramipexole in restless legs syndrome","volume":"13","author":"Montplaisir","year":"2006","journal-title":"Eur J Neurol"},{"issue":"7\u20138","key":"10.1016\/j.sleep.2010.11.002_b0035","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.sleep.2006.09.009","article-title":"A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome","volume":"8","author":"Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2010.11.002_b0040","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.sleep.2010.11.002_b0045","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/01.WNL.0000124465.20878.84","article-title":"Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study","volume":"62","author":"Trenkwalder","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.sleep.2010.11.002_b0050","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.11.002_b0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/sleep\/19.10.801","article-title":"Pergolide and carbidopa\/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients","volume":"19","author":"Earley","year":"1996","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleep.2010.11.002_b0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/sleep\/26.7.819","article-title":"Pramipexole in the management of restless legs syndrome: an extended study","volume":"26","author":"Silber","year":"2003","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2010.11.002_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2003.07.005","article-title":"Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)","volume":"5","author":"Winkelman","year":"2004","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2010.11.002_b0070","first-page":"970","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review","volume":"22","author":"Hening","year":"1999","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2010.11.002_b0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.21342","article-title":"Augmentation of restless legs syndrome with long-term tramadol treatment","volume":"22","author":"Vetrugno","year":"2007","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.sleep.2010.11.002_b0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.sleep.2006.05.011","article-title":"Restless legs syndrome augmentation associated with tramadol","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2010.11.002_b0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.11.002_b0090","first-page":"184","article-title":"An open label clinical trial with structured subjective reports and objective leg activity measures comparing gabapentin with alternative treatment in the restless legs syndrome","volume":"25","author":"Allen","year":"1996","journal-title":"Sleep Res"},{"issue":"3","key":"10.1016\/j.sleep.2010.11.002_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.20359","article-title":"Methadone for refractory restless legs syndrome","volume":"20","author":"Ondo","year":"2005","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.sleep.2010.11.002_b0100","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.23157","article-title":"Schollmayer E; SP792 Study Group. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled tiral in the United States","volume":"25","author":"Hening","year":"2010","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.sleep.2010.11.002_b0105","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945710003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945710003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:21:00Z","timestamp":1559931660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945710003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1389945710003710"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2010.11.002","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}